These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31715321)

  • 1. In vitro evaluation of the antibacterial activities of radezolid and linezolid for Streptococcus agalactiae.
    Zheng JX; Chen Z; Xu ZC; Chen JW; Xu GJ; Sun X; Yu ZJ; Qu D
    Microb Pathog; 2020 Feb; 139():103866. PubMed ID: 31715321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of radezolid against Enterococcus faecium and compared with linezolid.
    Xu Z; Wei Y; Wang Y; Xu G; Cheng H; Chen J; Yu Z; Chen Z; Zheng J
    J Antibiot (Tokyo); 2020 Dec; 73(12):845-851. PubMed ID: 32678335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Anti-Microbic and Anti-Biofilm Activity Among Tedizolid and Radezolid Against Linezolid-Resistant
    Wang L; Zhang Y; Liu S; Huang N; Zeng W; Xu W; Zhou T; Shen M
    Infect Drug Resist; 2021; 14():4619-4627. PubMed ID: 34764658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
    Chen KH; Huang YT; Liao CH; Sheng WH; Hsueh PR
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6262-5. PubMed ID: 26248355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radezolid Is More Effective Than Linezolid Against Planktonic Cells and Inhibits
    Zheng J; Chen Z; Lin Z; Sun X; Bai B; Xu G; Chen J; Yu Z; Qu D
    Front Microbiol; 2020; 11():196. PubMed ID: 32117185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology and molecular characteristics of linezolid-resistant
    Ding L; Li P; Yang Y; Lin D; Xu X
    J Med Microbiol; 2020 Aug; 69(8):1079-1088. PubMed ID: 32729813
    [No Abstract]   [Full Text] [Related]  

  • 7. Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms.
    Mendes RE; Deshpande LM; Jones RN
    Drug Resist Updat; 2014 Apr; 17(1-2):1-12. PubMed ID: 24880801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of
    Park K; Jeong YS; Chang J; Sung H; Kim MN
    Ann Lab Med; 2020 Jul; 40(4):321-325. PubMed ID: 32067432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of the optrA gene in Enterococcus isolates at a tertiary care hospital in China.
    Zhou W; Gao S; Xu H; Zhang Z; Chen F; Shen H; Zhang C
    J Glob Antimicrob Resist; 2019 Jun; 17():180-186. PubMed ID: 30641287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance mechanisms of linezolid-nonsusceptible enterococci in Korea: low rate of 23S rRNA mutations in Enterococcus faecium.
    Lee SM; Huh HJ; Song DJ; Shim HJ; Park KS; Kang CI; Ki CS; Lee NY
    J Med Microbiol; 2017 Dec; 66(12):1730-1735. PubMed ID: 29111969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial and anti-biofilm activity of radezolid against
    Wang C; Xiong Y; Bao C; Wei Y; Wen Z; Cao X; Yu Z; Deng X; Li G; Deng Q
    Front Microbiol; 2023; 14():1131178. PubMed ID: 37180277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus.
    Morales G; Picazo JJ; Baos E; Candel FJ; Arribi A; Peláez B; Andrade R; de la Torre MA; Fereres J; Sánchez-García M
    Clin Infect Dis; 2010 Mar; 50(6):821-5. PubMed ID: 20144045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countries.
    Mendes RE; Deshpande L; Streit JM; Sader HS; Castanheira M; Hogan PA; Flamm RK
    J Antimicrob Chemother; 2018 Jul; 73(7):1880-1887. PubMed ID: 29659858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.
    Chen H; Wu W; Ni M; Liu Y; Zhang J; Xia F; He W; Wang Q; Wang Z; Cao B; Wang H
    Int J Antimicrob Agents; 2013 Oct; 42(4):317-21. PubMed ID: 23880167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence and dissemination of a linezolid-resistant Staphylococcus capitis clone in Europe.
    Butin M; Martins-Simões P; Pichon B; Leyssene D; Bordes-Couecou S; Meugnier H; Rouard C; Lemaitre N; Schramm F; Kearns A; Spiliopoulou I; Hyyryläinen HL; Dumitrescu O; Vandenesch F; Dupieux C; Laurent F
    J Antimicrob Chemother; 2017 Apr; 72(4):1014-1020. PubMed ID: 27999045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of linezolid-resistant CoNS isolates in Japan.
    Takaya A; Kimura A; Sato Y; Ishiwada N; Watanabe M; Matsui M; Shibayama K; Yamamoto T
    J Antimicrob Chemother; 2015 Mar; 70(3):658-63. PubMed ID: 25381168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci.
    Livermore DM; Mushtaq S; Warner M; Woodford N
    J Antimicrob Chemother; 2009 Apr; 63(4):713-5. PubMed ID: 19164418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antimicrobial efficacy of eravacycline and tigecycline against clinical isolates of Streptococcus agalactiae in China: In vitro activity, heteroresistance, and cross-resistance.
    Li P; Wei Y; Li G; Cheng H; Xu Z; Yu Z; Deng Q; Shi Y
    Microb Pathog; 2020 Dec; 149():104502. PubMed ID: 32947016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of
    Zong Z; Jing W; Shi J; Wen S; Zhang T; Huo F; Shang Y; Liang Q; Huang H; Pang Y
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program.
    Deshpande LM; Castanheira M; Flamm RK; Mendes RE
    J Antimicrob Chemother; 2018 Sep; 73(9):2314-2322. PubMed ID: 29878213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.